CA

Shucui Jiang

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Libramen Naturals Inc.. Active years: 2018-2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shucui Jiang: Innovator in G-Protein Coupled Receptor Research

Introduction

Shucui Jiang is a notable inventor based in California, recognized for his contributions to the field of biochemistry and molecular biology. He holds 2 patents that focus on the development of transformed cell lines for studying guanosine-responsive G-protein coupled receptors.

Latest Patents

Jiang's latest patents include innovative techniques for transforming cell lines to express G-Protein Coupled Receptor GPCR22. The first patent discloses methods for identifying guanosine analogues and other ligands to the receptor. It details the transformation of Drosophila Schneider 2 cells and human astrocytoma 1321N1 cells to express GPCR22. These transformed cell lines are instrumental in identifying guanosine analogues and their functional equivalents. The second patent reiterates these techniques and emphasizes the utility of GPCR22-transformed cell lines in identifying binding compounds.

Career Highlights

Shucui Jiang is currently associated with Libramen Naturals Inc., where he continues to advance his research in the field. His work has significant implications for drug discovery and therapeutic applications.

Collaborations

Jiang collaborates with esteemed colleagues, including Michel P Rathbone and Francesco Caciagli, enhancing the scope and impact of his research.

Conclusion

Shucui Jiang's innovative work in the realm of G-protein coupled receptors showcases his commitment to advancing scientific knowledge and therapeutic possibilities. His contributions are paving the way for future discoveries in biochemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…